Skip to Content
MDPIMDPI

1 Result Found

  • Case Report
  • Open Access
3 Citations
1,959 Views
8 Pages
Download PDF

Mixed Infectious–Immune Pneumonitis Associated with PD-L1 Blockade: A Case of Durvalumab-Induced Lung Injury Complicated by Human Metapneumovirus Infection

  • Luca Pipitò,
  • Chiara Vincenza Mazzola,
  • Ilenia Giacchino,
  • Riccardo De Rosa and ,
  • Carola Maria Gagliardo,
  • Alessio Giuseppe Lipari,
  • Paola Monte,
  • Federica Furia,
  • Erika Mannino and
  • Antonio Cascio
  • + 7 authors+ 2 authors
J. Clin. Med.2026, 15(1), 251;https://doi.org/10.3390/jcm15010251

29 December 2025

Background: Durvalumab, a PD-L1 inhibitor used as consolidation therapy after chemoradiation in unresectable stage III non–small cell lung cancer (NSCLC), can induce immune-related adverse events, among which immune-mediated pneumonitis represe...

(This article belongs to the Section Infectious Diseases)
Full Article